By the end of this lesson you understand the difference between price and value, and why that distinction is the starting point for everything this level develops.
\nLevel 2's Module 9 closed with a key distinction: business quality isn't the same as valuation. A company can have a real competitive advantage, consistent results over time, and no red-flag pattern in its financial statements, and still not be a good investment if you pay an excessive price for it. This level starts precisely where that question was left: how do you determine what price could justify that quality?
\nAnswering that requires distinguishing two ideas that everyday language often confuses: price and value.
\nPrice is what the market pays right now for a share -- it's the market price, already covered in Level 1: it's set in real time by supply and demand, changes constantly throughout the trading session, and is an objective, observable figure at any moment.
\nValue is different: it's what a rigorous analysis of the business -- its ability to generate cash, its competitive advantage, the quality of its results -- estimates the company is really worth. Unlike price, value isn't a figure the market publishes: it's an estimate, subject to the judgment and assumptions of whoever calculates it, and different analysts can arrive at different estimates for the same company. The process of estimating that value is what this level calls valuation.
\nPrice and value can coincide, but they don't have to. A company can trade below what a rigorous estimate considers its real value -- it's cheap -- or above it -- it's expensive -- regardless of how good it is as a business. That possible divergence between price and value is the reason this entire level exists: without it, it would be enough to buy the highest-quality companies, regardless of price.
\nTwo companies can have exactly the same quality -- the same competitive advantage, the same consistent results -- and still be very different investments if one trades well above its estimated value and the other trades near it, or below: the quality of the business alone says nothing about whether the current price is reasonable.
\nPrice is what the market pays right now for a share -- the market price, an observable figure. Value is what a rigorous analysis estimates the company is really worth -- an estimate, not a market figure. Valuation is the process of estimating that value, and price and value can diverge in either direction.
\nWhy can a quality company, even so, not be a good investment at any price?
\nWhat's the difference between a share's observable price and its estimated value?
","sortOrder":1,"readingMinutes":8,"difficulty":"Básico"},"previous":null,"next":{"id":54,"moduleId":19,"slug":"what-methods-exist-for-valuing-a-company","title":"What methods exist for valuing a company?","summary":"You get an overview of the methods that exist for estimating a company's value, without yet going into the detail of any of them.","bodyMarkdown":"## Objectives\n\nBy the end of this lesson you get an overview of the methods that exist for estimating a company's value, without yet going into the detail of any of them.\n\n## Content\n\nThe previous lesson left a question open: if a company's value isn't an observable figure like price, but an estimate, how do you arrive at that estimate? There's no single correct method -- there are different families of methods, each with its own logic, and this level develops the two main ones in its next modules: discounted cash flow and comparable multiples.\n\nThe first family -- discounted cash flow, or DCF -- is based on projecting the future cash flows a company will generate, and bringing them to present value: calculating how much the euros the company will generate in the future are worth today, adjusting for the fact that a euro in ten years is worth less than a euro today. That adjustment requires a discount rate, a more precise version of the cost of capital, already covered in general terms in Level 2, which this level will develop in its own module further ahead.\n\nThe second family -- multiples -- is based on comparables: instead of projecting the company's future, it's compared with other similar companies using market ratios, for example how much the market pays for each euro the company earns or for each euro it bills. It's a faster method to apply, but it depends critically on choosing the comparable companies well.\n\nNeither family is automatically superior to the other -- they answer slightly different questions, and in practice they're often used together, as a way of cross-checking one estimate against another. This level's next modules develop each method separately, with the detail needed to apply it; this lesson only sketches the map.\n\n## Example\n\nTwo analysts can value the same company with different methods -- one projecting its future cash flows, another comparing it with similar companies -- and arrive at similar estimates, which reinforce each other, or at different estimates, which invite a review of each method's assumptions.\n\n## Common mistakes\n\n- Thinking there's a single \"correct\" valuation method -- different methods, applied carefully, are complementary ways of approaching the same question.\n- Confusing knowing the landscape of methods with knowing how to apply them -- this lesson presents the map; each method is developed in depth in its own module in this level.\n\n## Summary\n\nThere are two main families of valuation methods: discounted cash flow, which projects a company's future cash and brings it to present value, and multiples, which compare the company with similar ones using market ratios. Neither is automatically superior; each is developed in detail in this level's next modules.\n\n## Self-check\n\nWhat's the difference between a method based on future cash flows and one based on comparables?\n\nWhy isn't there a single \"correct\" method for valuing a company?","bodyHtml":"By the end of this lesson you get an overview of the methods that exist for estimating a company's value, without yet going into the detail of any of them.
\nThe previous lesson left a question open: if a company's value isn't an observable figure like price, but an estimate, how do you arrive at that estimate? There's no single correct method -- there are different families of methods, each with its own logic, and this level develops the two main ones in its next modules: discounted cash flow and comparable multiples.
\nThe first family -- discounted cash flow, or DCF -- is based on projecting the future cash flows a company will generate, and bringing them to present value: calculating how much the euros the company will generate in the future are worth today, adjusting for the fact that a euro in ten years is worth less than a euro today. That adjustment requires a discount rate, a more precise version of the cost of capital, already covered in general terms in Level 2, which this level will develop in its own module further ahead.
\nThe second family -- multiples -- is based on comparables: instead of projecting the company's future, it's compared with other similar companies using market ratios, for example how much the market pays for each euro the company earns or for each euro it bills. It's a faster method to apply, but it depends critically on choosing the comparable companies well.
\nNeither family is automatically superior to the other -- they answer slightly different questions, and in practice they're often used together, as a way of cross-checking one estimate against another. This level's next modules develop each method separately, with the detail needed to apply it; this lesson only sketches the map.
\nTwo analysts can value the same company with different methods -- one projecting its future cash flows, another comparing it with similar companies -- and arrive at similar estimates, which reinforce each other, or at different estimates, which invite a review of each method's assumptions.
\nThere are two main families of valuation methods: discounted cash flow, which projects a company's future cash and brings it to present value, and multiples, which compare the company with similar ones using market ratios. Neither is automatically superior; each is developed in detail in this level's next modules.
\nWhat's the difference between a method based on future cash flows and one based on comparables?
\nWhy isn't there a single "correct" method for valuing a company?
","sortOrder":2,"readingMinutes":8,"difficulty":"Básico"},"pathContext":null,"curatedLinks":{"prerequisite":[],"continuation":[],"related":[{"lesson":{"id":52,"moduleId":18,"slug":"what-red-flags-can-appear-in-financial-statements","title":"What red flags can appear in financial statements?","summary":"You recognize the most important red flags in real financial statements, synthesizing patterns already covered in earlier modules, and understand why business quality isn't the same as valuation.","bodyMarkdown":"## Objectives\n\nBy the end of this lesson you recognize the most important red flags in real financial statements, synthesizing patterns already covered in earlier modules, and understand why business quality isn't the same as valuation.\n\n## Content\n\nThe two previous lessons set up the framework: a real competitive advantage is proven through consistency of results over time, not a one-off good quarter. This last lesson brings together, as a critical-reading criterion, three patterns already taught separately throughout this level -- it doesn't introduce new analysis tools, it just connects them.\n\nThe first signal is a non-recurring item that stops being one. You already saw in Module 2 that a non-recurring item is, by definition, a one-off element that isn't part of the company's normal activity. If that same label appears period after period, something doesn't add up: either it isn't really non-recurring, or it's being used to dress up a result that, without it, would be worse.\n\nThe second signal is a high ROE sustained by growing leverage without ROIC improving -- exactly the ROE limitation already covered in Modules 6 and 7. If the shareholder's return rises because the company is taking on more debt, not because the business is more efficient, that ROE says less than it appears to at first glance.\n\nThe third signal is positive accounting profit that isn't backed by Free Cash Flow, already covered in Module 4. Profit that exists on the income statement but hasn't yet turned into real cash deserves a closer look before accepting it at face value.\n\nNone of these three signals, on its own, automatically disqualifies a company -- each requires investigating the specific cause, with the same judgment already applied to each pattern separately in its own module. What changes here is that they're now read together, as part of the same quality exercise, not as three isolated checks.\n\nThis closes the module, and with it Level 2 as a whole: financial statements, ratios, ROE, ROIC, margins, and now business quality. But it's worth leaving one final distinction very clear before moving on: business quality isn't the same as valuation. A company can have a real competitive advantage, consistent results, and no red-flag pattern, and still be a bad investment if you pay too high a price for it. And conversely, a mediocre company can be a good investment if its price already reflects that mediocrity. This level has built the tools to answer \"is this a good company?\" -- the question of how much that company should cost, and whether its current price is reasonable, belongs to the next level in this curriculum.\n\n## Example\n\nA company can show the same net income two years running, but if in the second year that result includes a one-off asset sale that won't repeat, and its Free Cash Flow has fallen compared to the previous year, both signals point in the same direction: the reported result is less representative than it looks.\n\n## Common mistakes\n\n- Automatically ruling out a company because of a single red flag, without investigating the specific cause -- each signal requires context, not an automatic veto.\n- Confusing a quality company with a good investment -- they're different questions: quality values the business, valuation values the price paid for it.\n\n## Summary\n\nRed flags -- repeating non-recurring items, ROE inflated by leverage without ROIC improving, and accounting profit without Free Cash Flow to back it up -- are patterns already taught that, read together, complete this level's quality criteria. Business quality and valuation are different questions: the latter belongs to the next level.\n\n## Self-check\n\nWhy does a \"non-recurring\" item that appears several periods in a row stop living up to its own name?\n\nWhy can a quality company, even so, be a bad investment?","bodyHtml":"By the end of this lesson you recognize the most important red flags in real financial statements, synthesizing patterns already covered in earlier modules, and understand why business quality isn't the same as valuation.
\nThe two previous lessons set up the framework: a real competitive advantage is proven through consistency of results over time, not a one-off good quarter. This last lesson brings together, as a critical-reading criterion, three patterns already taught separately throughout this level -- it doesn't introduce new analysis tools, it just connects them.
\nThe first signal is a non-recurring item that stops being one. You already saw in Module 2 that a non-recurring item is, by definition, a one-off element that isn't part of the company's normal activity. If that same label appears period after period, something doesn't add up: either it isn't really non-recurring, or it's being used to dress up a result that, without it, would be worse.
\nThe second signal is a high ROE sustained by growing leverage without ROIC improving -- exactly the ROE limitation already covered in Modules 6 and 7. If the shareholder's return rises because the company is taking on more debt, not because the business is more efficient, that ROE says less than it appears to at first glance.
\nThe third signal is positive accounting profit that isn't backed by Free Cash Flow, already covered in Module 4. Profit that exists on the income statement but hasn't yet turned into real cash deserves a closer look before accepting it at face value.
\nNone of these three signals, on its own, automatically disqualifies a company -- each requires investigating the specific cause, with the same judgment already applied to each pattern separately in its own module. What changes here is that they're now read together, as part of the same quality exercise, not as three isolated checks.
\nThis closes the module, and with it Level 2 as a whole: financial statements, ratios, ROE, ROIC, margins, and now business quality. But it's worth leaving one final distinction very clear before moving on: business quality isn't the same as valuation. A company can have a real competitive advantage, consistent results, and no red-flag pattern, and still be a bad investment if you pay too high a price for it. And conversely, a mediocre company can be a good investment if its price already reflects that mediocrity. This level has built the tools to answer "is this a good company?" -- the question of how much that company should cost, and whether its current price is reasonable, belongs to the next level in this curriculum.
\nA company can show the same net income two years running, but if in the second year that result includes a one-off asset sale that won't repeat, and its Free Cash Flow has fallen compared to the previous year, both signals point in the same direction: the reported result is less representative than it looks.
\nRed flags -- repeating non-recurring items, ROE inflated by leverage without ROIC improving, and accounting profit without Free Cash Flow to back it up -- are patterns already taught that, read together, complete this level's quality criteria. Business quality and valuation are different questions: the latter belongs to the next level.
\nWhy does a "non-recurring" item that appears several periods in a row stop living up to its own name?
\nWhy can a quality company, even so, be a bad investment?
","sortOrder":3,"readingMinutes":10,"difficulty":"Intermedio"},"route":{"levelSlug":"business-analysis","moduleSlug":"business-quality"}}]},"relatedConcepts":[{"concept":{"id":67,"slug":"valuation","term":"Valuation","shortDefinition":"The process of estimating how much a company is really worth, beyond what its market price indicates at a given moment.","longDefinition":"Valuation is the process of estimating a company's value -- what a rigorous analysis of its business, its ability to generate cash, and its competitive advantage suggests it's worth -- as distinct from its market price, which is simply what the market is trading it for at any given moment. Price and value can coincide, but they can also diverge in either direction: a company can trade above or below what a rigorous estimate considers its real value. There's no single valuation method: different families of methods -- projecting a company's future cash flows, or comparing it with similar companies using market ratios -- are complementary ways of approaching the same question, each with its own assumptions and limitations."}}]}